Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ZYME
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 74,360 Added 0.0% |
$881,166
$11.85 p/Share
|
Apr 02
2025 |
|
CVNA
|
Benjamin E. Huston
Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct | 50,000 Added 22.34% |
-
|
Apr 02
2025 |
|
SDHI
|
Brian D Finn
Director |
BUY
Open market or private purchase
|
Indirect | 338,000 Added 0.0% |
-
|
Apr 02
2025 |
|
FGBI
|
Edgar R. Smith Iii
Director |
BUY
Open market or private purchase
|
Indirect | 98,460 Added 0.0% |
$833,956
$8.47 p/Share
|
Apr 02
2025 |
|
SDHI
|
Siddhi Sponsor LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 338,000 Added 4.46% |
-
|
Apr 02
2025 |
|
ADVM
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect | 15,209 Added 0.0% |
$61,444
$4.04 p/Share
|
Apr 02
2025 |
|
MRMD
|
Jon R Levine
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,984 Reduced 0.04% |
$798
$0.1 p/Share
|
Apr 02
2025 |
|
MRMD
|
Jon R Levine
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 23,041 Added 0.11% |
-
|
Apr 02
2025 |
|
MRMD
|
Timothy Shaw
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 19,969 Added 0.23% |
-
|
Apr 02
2025 |
|
MRMD
|
Timothy Shaw
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,920 Reduced 0.08% |
$692
$0.1 p/Share
|
Apr 02
2025 |
|
PPBI
|
Michael S Karr
SEVP & Chief Risk Officer |
SELL
Bona fide gift
|
Direct | 1,384 Reduced 4.32% |
-
|
Apr 02
2025 |
|
PPBI
|
Michael S Karr
SEVP & Chief Risk Officer |
BUY
Bona fide gift
|
Indirect | 1,384 Added 0.0% |
-
|
Apr 02
2025 |
|
PPBI
|
Tom Rice
SEVP/ Chief Innovation Officer |
SELL
Bona fide gift
|
Direct | 1,898 Reduced 5.83% |
-
|
Apr 02
2025 |
|
PPBI
|
Tom Rice
SEVP/ Chief Innovation Officer |
BUY
Bona fide gift
|
Indirect | 1,898 Added 0.0% |
-
|
Apr 02
2025 |
|
JLS
|
Aashh Parekh |
BUY
Open market or private purchase
|
Direct | 100 Added 2.17% |
$1,825
$18.25 p/Share
|
Apr 02
2025 |
|
AVMR
|
Barry F Cohen
COO - Americas |
BUY
Open market or private purchase
|
Direct | 420 Added 0.0% |
$3,863
$9.2 p/Share
|
Apr 02
2025 |
|
ITCI
|
Michael Halstead
President |
SELL
Sale (or disposition) back to the issuer
|
Direct | 21,307 Reduced 100.0% |
$2,812,524
$132.0 p/Share
|
Apr 02
2025 |
|
VEEV
|
Jonathan Faddis
SVP, Gen. Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 787 Reduced 8.32% |
$178,019
$226.2 p/Share
|
Apr 02
2025 |
|
ITCI
|
Rory B Riggs |
SELL
Sale (or disposition) back to the issuer
|
Direct | 131,512 Reduced 100.0% |
$17,359,584
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Mark Neumann
EVP, Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 52,811 Reduced 100.0% |
$6,971,052
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Robert L Van Nostrand |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,340 Reduced 100.0% |
$1,496,880
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Suresh K. Durgam
EVP, Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 42,913 Reduced 100.0% |
$5,664,516
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Sharon Mates
Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 945,235 Reduced 100.0% |
$124,771,020
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Sharon Mates
Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 190,000 Reduced 0.0% |
$25,080,000
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Direct | 48,238 Reduced 100.0% |
$6,367,416
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 10,000 Reduced 0.0% |
$1,320,000
$132.0 p/Share
|
Apr 02
2025 |
|
SHIM
|
Mitchell B. Goldsteen |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$3,520
$1.76 p/Share
|
Apr 02
2025 |
|
UAVS
|
Adrienne Anderson
Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 33.33% |
-
|
Apr 02
2025 |
|
LXP
|
Arun Gupta
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 4.58% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Lawrence L Gray
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 50.0% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Nancy Elizabeth Noe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 50.0% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Claire A Koeneman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.1% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Derrick L Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 8.84% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Jamie Handwerker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.26% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Howard Stewart Roth
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.75% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
DCGO
|
Stephen Sugrue
Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,614 Reduced 1.59% |
$15,045
$2.68 p/Share
|
Apr 02
2025 |
|
DCGO
|
Lee Bienstock
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 18,598 Reduced 0.94% |
$49,842
$2.68 p/Share
|
Apr 02
2025 |
|
DCGO
|
Norman Rosenberg
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,004 Reduced 0.93% |
$21,450
$2.68 p/Share
|
Apr 02
2025 |
|
KRMD
|
Shahriar Matin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,870 Added 6.57% |
$15,027
$2.56 p/Share
|
Apr 02
2025 |
|
KRMD
|
Edward Wholihan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,870 Added 14.88% |
$15,027
$2.56 p/Share
|
Apr 02
2025 |
|
TBNK
|
Kirk W Caldwell
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 34,227 Reduced 100.0% |
-
|
Apr 02
2025 |
|
TBNK
|
Allan S Kitagawa
Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 166,491 Reduced 100.0% |
-
|
Apr 02
2025 |
|
TBNK
|
Allan S Kitagawa
Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 92,550 Reduced 0.0% |
-
|
Apr 02
2025 |
|
KRMD
|
Robert Cascella
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,870 Added 6.8% |
$15,027
$2.56 p/Share
|
Apr 02
2025 |
|
KRMD
|
R John Fletcher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,806 Added 4.11% |
$22,543
$2.56 p/Share
|
Apr 02
2025 |
|
KRMD
|
Donna French
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,870 Added 6.77% |
$15,027
$2.56 p/Share
|
Apr 02
2025 |
|
TBNK
|
John M Ohama
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 10,000 Reduced 0.0% |
-
|
Apr 02
2025 |
|
LYTS
|
Chantel E Lenard |
BUY
Grant, award, or other acquisition
|
Direct | 1,080 Added 3.03% |
$18,748
$17.36 p/Share
|
Apr 02
2025 |
|
TBNK
|
Howard Y Ikeda
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 27,078 Reduced 100.0% |
-
|
Apr 02
2025 |
|
TBNK
|
Howard Y Ikeda
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 13,222 Reduced 0.0% |
-
|
Apr 02
2025 |